Increased central AT1-receptor activation, not systemic vasopressin, sustains hypertension in ANP knockout mice

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 278, Issue 6 47-6, 2000, Pages

  Ackermann, Uwe ^a   Azizi, Newsha ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Angiotensin II; Atrial natriuretic peptide; Blood pressure; Central nervous system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ATRIAL NATRIURETIC FACTOR; LOSARTAN; VASOPRESSIN; VASOPRESSIN ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DNA MODIFICATION; HYPERTENSION; KNOCKOUT MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; VASOPRESSIN RELEASE;

EID: 0033946124     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.2000.278.6.r1441     Document Type: Article

References (42)

1. Antunes-Rodrigues J, McCann SM, and Samson WK. Central administration of atrial natriuretic factor inhibits saline preference in the rat. Endocrinology 118: 1726-1728, 1986.
2. Barbee RW, Perry BD, Re RN, Murgo JP, and Field LJ. Hemodynamics in transgenic mice with overexpression of atrial natriuretic factor. Circ Res 74: 747-751, 1994.
3. Casto R, Hilbig J, Schroeder G, and Stock G. Atrial natriuretic factor inhibits central angiotensin II pressor responses. Hypertension 9: 473-477, 1987.
4. Charles CJ, Richards AM, and Espiner EA. Central C-type natriuretic peptide but not atrial natriuretic factor lowers blood pressure and adrenocortical secretion in normal conscious sheep. Endocrinology 131: 1721-1726, 1992.
5. Davisson RL, Yang G, Beltz TG, Cassell MD, Johnson AK, and Sigmund CD. The brain renin-angiotensin system contributes to the hypertension in mice containing both the human renin and human angiotensinogen transgenes. Circ Res 83: 1047-1058, 1998.
6. Faber JE. Lack of an effect of atrial natriuretic peptide on myogenic contraction of microvascular smooth muscle. Am J Physiol Heart Circ Physiol 258: H419-H423, 1990.
7. Faison EP, Siegl PKS, Morgan G, and Winquist RJ. Regional vasorelaxant selectivity of atrial natriuretic factor in isolated rabbit vessels. Life Sci 37: 1073-1079, 1985.
8. Field LJ, Veress AT, Steinhelper ME, Cochrane KL, and Sonnenberg H. Kidney function in ANF-transgenic mice: effect of blood volume expansion. Am J Physiol Regulatory Integrative Comp Physiol 260: R1-R5, 1991.
9. Franklin KBJ and Paxinos G. The Mouse Brain in Stereotaxic Coordinates. New York: Academic, 1997.
10. Gaudet EA, Godwin SJ, and Head GA. Role of central catecholaminergic pathways in the actions of endogenous ANGII on sympathetic reflexes. Am J Physiol Regulatory Integrative Comp Physiol 275: R1174-R1184, 1998.
11. Harris MC and Loewy AD. Neural regulation of vasopressin-containing hypothalamic neurons and the role of vasopressin in cardiovascular function. In: Central Regulation of Autonomic Functions, edited by Loewy AD and Spyer KM. Oxford, UK: Oxford University Press, 1990, p. 224-246.
12. Hattori Y, Kasai M, and Uesugi S. Atrial natriuretic peptide depresses angiotensin II-induced excitation of neurons in the rat subfornical organ in vitro. Brain Res 443: 355-359, 1988.
13. Inagami T, Tanaka I, McKenzie JC, Nakamura M, Takaianagi R, Imada T, Pochet R, Resibois A, Naruse M, and Naruse K. Discovery of atrial natriuretic factor in the brain: its characterization and cardiovacular implication. Cell Mol Neurobiol 9: 75-85, 1989.
14. Jezova D, Ochedalski T, Kiss A, and Aguilera G. Brain angiotensin II modulates sympathoadrenal and hypothalamic pituitary adrenocortical activation during stress. J Neurol Neurosurg Psychiatry 10: 67-72, 1998.
15. John SWM, Krege JH, Oliver P, Hagaman J, Hodgin JB, Pang SC, Flynn TG, and Smithies O. Genetically decreased levels of atrial natriuretic peptide and salt-sensitive hypertension. Science 267: 679-681, 1995.
16. John SWM, Veress AT, Honrath U, Chong CK, Peng L, Smithies O, and Sonnenberg H. Blood pressure and fluidelectrolyte balance in mice with reduced or absent ANP. Am J Physiol Regulatory Integrative Comp Physiol 271: R109-R114, 1996.
17. King KA and Ledsome JR. Atrial dynamics, atrial natriuretic factor, tachycardia, and blood volume in anesthetized rabbits. Am J Physiol Heart Circ Physiol 261: H22-H28, 1991.
18. Kupfermann I. Hypothalamus and limbic system: peptidergic neurons, homeostasis, and emotional behavior. In: Principles of Neural Science, edited by Kandel ER, Schwartz ER, and Jessel TM. New York: Elsevier, 1991, p. 735-760.
19. Lappe RW, Dinish JL, Bex F, Michalak K, and Wendt RL. Effects of atrial natriuretic factor on drinking responses to central angiotensin II. Pharmacol Biochem Behav 24: 1573-1576, 1986.
20. 2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review. Front Neuroendocrinol 18: 383-439, 1997.
21. Levin ER, Weber MA, and Mills S. Atrial natriuretic factor-induced vasodepression occurs through central nervous system. Am J Physiol Heart Circ Physiol 255: H616-H622, 1988.
22. Melo LG, Veress AT, Ackermann U, and Sonnenberg H. Chronic regulation of arterial blood pressure by ANP: role of endogenous vasoactive endothelial factors. Am J Physiol Heart Circ Physiol 275: H1826-H1833, 1998.
23. Melo LG, Veress AT, Ackermann U, Steinhelper ME, Pang SC, Tse Y, and Sonnenberg H. Chronic regulation of blood pressure by ANP: role of cardiovascular sympathetic tone. Cardiovasc Res 43: 437-444, 1999.
24. Nakao K, Morii N, Itoh H, Yamada T, Shiono S, Sugawara A, Saito Y, Mukoyama M, Arai H, Sakamoto M, and Imura H. Atrial natriuretic polypeptide in the brain: Implication of central cardiovascular control. J Hypertens 4, Suppl. 6: S492-S496, 1986.
25. Obana K, Naruse M, Inagami T, Brown AB, Naruse K, Kurimoto F, Sakurai H, Demura H, and Shizume K. Atrial natriuretic factor inhibits vasopressin secretion from rat posterior pituitary. Biochem Biophys Res Commun 132: 1088-1094, 1985.
26. Obermueller N, Unger T, Culman J, Gohlke P, De-Gasparo M, and Bottari SP. Distribution of angiotensin II receptor subtypes in rat brain nuclei. Neurosci Lett 132: 11-15, 1991.
27. Osol G, Halpern W, Tesfamariam B, Nakayama K, and Weinberg D. Synthetic atrial natriuretic factor does not dilate resistance-sized arteries. Hypertension 8: 606-610, 1986.
28. Ranson SW and Clark SL. The Anatomy of the Nervous System. Its Development and Function. Philadelphia, PA: Saunders, 1959.
29. Saavedra JM, Correa FMA, Plunkett LM, Iarael A, Kurihara M, and Shigematsu K. Binding of angiotensin and atrial natriuretic peptide in brain of hypertensive rats. Nature 320: 758-760, 1986.
30. Samson WK. Atrial natriuretic factor inhibits dehydration and hemorrhage-induced vasopressin release. Neuroendocrinology 40: 277-279, 1985.
31. Saper CB, Standaert DG, Currie MG, Schwartz D, Geller DM, and Needleman P. Atriopeptin-immunoreactive neurons in the brain: presence in cardiovascular regulatory areas. Science 227: 1047-1049, 1985.
32. Shimizu T, Katsuura G, Nakamura M, Nakao K, Morii N, Itoh Y, Shiono S, and Imura H. Effect of intracerebroventricular ANP on blood pressure and urine production in rats. Life Sci 39: 1263-1270, 1986.
33. Sladek CD. Regulation of vasopressin release by neurotransmitters, neuropeptides and osmotic stimuli. In: The Neurohypophysis, edited by Cross BA and Leng G. Amsterdam, The Netherlands: Elsevier, 1983, p. 71-90.
34. Steardo L, Steardo MD, Testa N, Attanasio A, Persichella M, and Cuomo V. Atrial natriuretic factor antagonises angiotensin II-induced vasopressin release in rat subfornical organ. Acta Neurol (Napoli) 16: 229-234, 1994.
35. Steele MK, Gardner DG, Xie PL, and Schultz HD. Interactions between ANP and ANG II regulating blood pressure and sympathetic outflow. Am J Physiol Regulatory Integrative Comp Physiol 260: R1145-R1151, 1991.
36. Steinhelper ME, Cochrane KL, and Field LJ. Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes. Hypertension 16: 301-307, 1990.
37. Suga S-I, Nakao K, Kishimoto I, Hosoda K, Mukoyama M, Arai H, Shirakami G, Ogawa Y, Komatsu Y, Nakagawa O, Hama N, and Imura H. Phenotype-related alteration in expression of natriuretic peptide receptors in aortic smooth muscle cells. Circ Res 71: 34-39, 1992.
38. Tang J, Fei H, Xie W, Suen MZ, Han JS, Webber D, Chang J, and Chang JK. Characterization and localization of atriopeptin in rat atrium. Peptides 5: 1173-1177, 1984.
39. Thoren PN, Mark AL, Morgan DA, O'Neill TP, Needleman P, and Brody MJ. Activation of vagal depressor reflexes by atriopeptins inhibits renal sympathetic nerve activity. Am J Physiol Heart Circ Physiol 251: H1252-H1259, 1986.
40. Ullman J. Vasopressin and angiotensin II in blood pressure control during isoflurane anesthesia in rats. Acta Anaesthesiol Scand 43: 860-865, 1999.
41. Widdop RE, Gardiner SM, and Bennett T. Effects of angiotensin II AT(1)- or AT(2)-receptor antagonists on drinking evoked by angiotensin II or water deprivation in rats. Brain Res 648: 46-52, 1994.
42. Yamada T, Nakao K, Morii N, Itoh H, Shiono S, Sakamoto M, Sugawara A, Saito Y, Ohno H, Kanai A, Katsuura G, Eigyo M, Matsushita A, and Imura H. Central effect of atrial natriuretic polypeptide on angiotensin II-stimulated vasopressin secretion in concious rats. Eur J Pharmacol 125: 453-456, 1986.